Portnoy Law Firm Announces Class Action on Behalf of ARS Pharmaceuticals, Inc. Investors
The Portnoy Law Firm announced a class action lawsuit on behalf of ARS Pharmaceuticals investors regarding securities purchased between March 9, 2026, and June 24, 2026. The complaint alleges that the company made misleading statements regarding the timeline for CVS Caremark's formulary addition and coverage of its needle-free epinephrine product, neffy.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.